Manufacturing roundup: Investment firm buys Pfizer facility in Australia; Cambrex opens new facility in Belgium
Private investment firm Bridgewest Group has closed its acquisition of a former Pfizer manufacturing site outside of Perth, Australia.
The new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
